Hemex Health Inc, founded in 2016, is dedicated to manufacturing diagnostic and medical instruments aimed at empowering frontline healthcare providers. Their core mission is to break barriers in healthcare diagnostics by offering inexpensive, portable, and easy-to-use devices. The flagship product, Gazelle®, provides affordable and accurate testing for conditions such as sickle cell disease, targeting underserved populations and remote locations where traditional diagnostic tools are impractical.
Notable figures affiliated with Hemex Health include industry experts and investors committed to advancing global health. Key achievements include the successful deployment of Gazelle® in challenging settings, significantly improving diagnostic capabilities in underserved areas. Hemex Health's impact is marked by its contribution to accessible healthcare, enabling timely and accurate diagnoses that can lead to better patient outcomes worldwide.
